Navigation Links
SPO Medical Unveils New Oximetry Devices for European Markets
Date:11/14/2007

PulseOx 6000(TM) and PulseOx 6100(TM) to be launched at MEDICA in Germany

NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- SPO Medical Inc. (OTC Bulletin Board: SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, today announced that the PulseOx 6000(TM) and PulseOx 6100(TM), two new oximetry devices, will be formally introduced to the public at the 39th MEDICA World Forum for Medicine in Dusseldorf, Germany between 14th - 17th November, 2007.

The PulseOx 6000(TM) (finger device) and PulseOx 6100(TM) (hand-held device) are both designed for medical professionals, hospitals and managed care facilities. Based on SPO Medical's proprietary patented algorithms, both the PulseOx 6000(TM) and PulseOx 6100(TM) use Reflective Pulse Oximetry (RPO) technology for accurate and reliable measurements of blood oxygen saturation and heart rate, utilizing new AutoSpot(TM) technology to read in low profusion measurements. The products have been granted CE Mark of approval by the European Union and will be commercially available early in the first quarter of 2008.

These ground-breaking medical devices follow the watershed success of the PulseOx 5500(TM). Earlier this year, the Company announced that it sold over 100,000 of the pulse oximetry units, marking a sales milestone that has been achieved within three years of the company's first introduction of the commercial product.

"We are thrilled to introduce the medical community to PulseOx 6000(TM) and PulseOx 6100(TM) at MEDICA, the leading medical exhibition in the world," said Michael Braunold, President and Chief Executive Officer of SPO Medical. "I am confident that SPO Medical will continue to unveil new life-saving and life-enhancing products and move forward in implementing a thoughtful strategy to expand our businesses."

MEDICA, the international hub for the medical trade, introduces the medical industry to the latest products for in-patient and out-patient care: electromedical and laboratory equipment, medical technology, diagnostics, pharmaceuticals and medical supplies as well as physiotherapy and orthopedic technology, communication and information technology, facility management, clothing, medical furniture and equipment and building technology. For more information on MEDICA, go to http://www.medica.de.

SPO Medical will be located in Hall 13/D 20 and their executives will be available to answer questions along with demonstrating the new product offerings.

About SPO Medical:

SPO Medical (SPOM) a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-saving and life-enhancing information within four key markets: medical care; home and remote-care; sports and wellness; and safety and security. Its patented technology uses information gathered from the reflectance of light on the human blood stream, in a non-invasive manner, to monitor key vital signs. The Company distributes its products through a network of distributors and also licenses its technologies to appropriate client corporations for commercialization and distribution. For more information, visit http://www.spomedical.com .

Safe Harbor

This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, changes in economic conditions generally and the medical devices market specifically, changes in technology, legislative or regulatory changes that affect us, the availability of working capital, changes in costs and the availability of goods and services, the introduction of competing products, planned product launches, changes in our operating strategy or development plans, our ability to attract and retain qualified personnel, and the risks and uncertainties discussed under the heading "Risk Factors" in Item 1 of our Annual Report on Form 10-KSB for the fiscal year ended December 31, 2006. We undertake no obligation to revise or update any forward-looking statement for any reason.


'/>"/>
SOURCE SPO Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
Breaking Medicine Technology: